Trill AB - 14 Aug 2025 SCHEDULE 13G/A Report for DiaMedica Therapeutics Inc. Common Shares, no par value (DMAC)

Filing Manager: Trill AB
Reporting Manager: Trill AB
Security: DiaMedica Therapeutics Inc. Common Shares, no par value
Symbol: DMAC
Shares outstanding: 51,694,174 shares
Disclosed Ownership: 7,764,465 shares
Ownership: 15%
Form type: SCHEDULE 13G/A
Filing time: 04 Sep 2025, 14:16:55 UTC
Date of event: 14 Aug 2025
Previous filing: 30 Jul 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Trill AB	15.02%	7,764,465	0	7,764,465	/s/ Jan Stahlberg	Jan Stahlberg/Board Member
Jan Stahlberg	15.02%	7,764,465	0	7,764,465	/s/ Jan Stahlberg	Jan Stahlberg